Bronchiolar complications of connective tissue disorders

Seminars in Respiratory and Critical Care Medicine

Volumn 20, Issue 2, 1999, Pages 149-168

  Lynch III, Joseph P ^a,c   Belperio, John ^a   Flint, Andrew ^b   Martinez, Fernando ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Airflow obstruction; Bronchiolitis; Bronchiolitis obliterans organizing pneumonia; Connective tissue diseases; Constrictive bronchiolitis; Cryptogenic organizing pneumonia; Obliterative bronchiolitis; Rheumatoid arthritis

Indexed keywords

AIRWAY OBSTRUCTION; BRONCHIOLITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; HISTOPATHOLOGY; HUMAN; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG PARENCHYMA; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SMALL AIRWAY DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032924733     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1009456     Document Type: Review

References (181)

1. Colby TV. Bronchiolar pathology. In: Epler GR, ed. Diseases of the Bronchioles. New York: Raven Press; 1094:77-100
2. Myers JL, Colby TV. Pathological manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993;14:611-622
3. Garg K, Lynch DA, Newell JD, King TE Jr. Proliferative and constrictive bronchiolitis: Classification and radiologic features. Am J Roentgenol 1994;162:803-808
4. Guerry-Force ML, Muller NL, Wright JL, et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonitis and small airways disease. Am Rev Respir Dis 1987;135:705-712
5. Katzenstein ALA, Myers JL, Prophet WD, Corley LS, Shin MS. Bronchiolitis obliterans and usual interstitial pneumonia: a comparative clinicopathologic study. Am J Surg Pathol 1986;106:373-381
6. King TE. Bronchiolitis. In: Fishman AP, ed. Fishman's Pulmonary Diseases and Disorders, 3rd ed. McGraw-Hill, New York 1997:825-847
7. Muller NL, Miller RR. Diseases of the bronchioles: CT and histopathologic findings. Radiology 1995;196:3-12
8. Gosink BB, Friedman PJ, Liebow AA. Bronchiolitis obliterans. Am J Roentgenol 1973;117:816-832
9. Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltimore) 1995;74:201-211
10. Banter T, Irwin RS, Nosh G, et al. Idiopathic bronchiolitis organizing pneumonia with peripheral infiltrates on chest roentgenogram. Arch Intern Med 1989;149:273-279
11. Cordier JF, Loire R, Brune J. Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients. Chest 1989; 96:999-1004
12. Costabel U, Teschler H, Schoenfeld B, et al. BOOP in Europe. Chest 1992;102(Suppl.):14S-20S
13. Davison AG, Heard BE, McAllister WAC, Turner-Warwick MEH. Cryptogenic organizing pneumonitis. Q J Med 1983;52:382-394
14. Flowers JR, Clunie G, Burke M, Constant O. Bronchiolitis obliterans organizing pneumonia: The clinical and radiological features of seven cases and a review of the literature. Clin Radiol 1992;45:371-377
15. Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312: 152-158
16. Izumi T, Kitaichi M, Nishimura K, Nagai S. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest 1992;102:715-719
17. King TE, Mortenson RL. Cryptogenic organizing pneumonitis: The North American experience. Chest 1992; 102(Suppl.):8S-13S
18. Lohr RH, Boland BJ, Douglas WW, Dockrell DH, et al. Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 1997;157:1323-1329
19. Yamamoto M, Iny Y, Kitaichi M, Harasawa M, Tamura M. Clinical features of BOOP in Japan. Chest 1992;102 (Suppl. 1):21S-25S
20. Ezri T, Kunichezky S, Eliraz A, Soroker D, Halperin D, Schattner A. Bronchiolitis obliterans: Current concepts. QJ Med 1994;87:1-10
21. Halpin DMG, Geddes DM. Rheumatoid arthritis and connective-tissue disease related bronchiolitis obliterans. In: ed. Epler GR, Diseases of the Bronchioles. Raven Press; New York: 1994:231-240
22. Hansell DM, Rubens MB, Padley SPG, Wells AU. Obliterative bronchiolitis: Individual CT signs of small airways disease and functional correlation. Radiology 1997;203: 721-726
23. Kelly K, Hertz MI. Obliterative bronchiolitis. Clin Chest Med 1997;18:319-338
24. Kindt GC, Weiland JE, Davis WB, Gadek JE, Dorinsky PM. Bronchiolitis in adults: A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis 1989;140:483-492
25. St. John RC, Dorinsky PM. Cryptogenic bronchiolitis. Clin Chest Med 1993;14:667-675
26. Thurlbeck WM. Chronic airflow obstruction. In Thurlbeck W. Churg A, eds. Pathology of the Lung, 2nd ed. New York: Thieme; 1995:739-825
27. Turton CW, Williams G, Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax 1981;36:805-810
28. Wright JL, Cagle P, Churg A, Colby TV, Myers J. Diseases of the small airways: State of the art. Am Rev Respir Dis 1992;146:240-262
29. Yousem SA, Colby T. Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol 1985;16:700-706
30. Lynch JP, III. Raghu G. Major Pulmonary disease syndromes of unknown etiology. In: Baum GL, Crapo JD, Celli BR, Karlinsky JB, eds. Textbook of Pulmonary Diseases, 6th ed. Philadelphia: Lippincott-Raven Publishers; 1998:431-476
31. Geddes DM, Corrin B, Brewerton DA, et al. Progressive airway obliteration in adults and its association with rheumatoid disease. QJ Med 1977;46:427-444
32. Hakler M, Paako P, Sutinen S, et al. Association of bronchiolitis with connective tissue disorders. Ann Rheum Dis 1986;45:656-662
33. Martinez F, Lynch JP III. Collagen vascular disease-associated bronchiolitis obliterans organizing pneumonia. In: Epler GR, ed. Diseases of the Bronchioles. New York: Raven Press; 1994:347-366
34. Wells A, DuBois R. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993;14:655-666
35. Myers JL, Kurtin PJ. Lymphoproliferative disorders of the lung. In: Thurlbeck W, Churg A. eds. Pathology of the Lung, 2nd ed. New York: Thieme; 1995:553-588
36. Pigula FA, Griffith BP, Zenati MA, Dauber JH, Yousem SA, Keenan RJ. Lung transplantation for respiratory failure resulting from systemic disease. Ann Thorac Surg 1997; 64:1630-1634
37. Hansell DM, Rubens MB, Padley SP, Wells AU. Obliterative bronchiolitis; individual CT signs of small airways disease and functional correlation. Radiology 1997;203:721-726
38. Sato A, Hayakawa H, Uchiyama H, Chida K. Cellular distribution of bronchus-associated lymphoid tissue in rheumatoid arthritis. Am J Respir Crit Care Med 1996;154: 1903-1907
39. Hayakawa H, Sato A, Imokawa S, Toyoshima M, Chida K, Iwata M. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996;154:1531-1536
40. Padley SPG, Adler BD, Hansell DM, et al. Bronchiolitis obliterans: High resolution CT findings and correlation with pulmonary function tests. Clin Radiol 1993;47:236-240
41. Swensen SJ, Aughenbaugh GL, Myers JL. Diffuse lung disease: Diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. Radiology 1997;205:229-234
42. Nishimura K, Itoh H. High resolution computed tomographic features of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(Suppl.):26S-31S
43. Aquino SL, Webb WR, Golden J. Bronchiolitis obliterans associated with rheumatoid arthritis: Findings on HRCT and dynamic expiratory CT. J Comput Assist Tomogr 1994;18:555-558
44. Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis. Clinical, functional, and HRCT findings. AmJ Respir Crit Care Med 1998;157:1658-1665
45. Bhalla M, Naidich DP, McGuinness G, Gruden JF, Leitman BS, McCauley DI. Diffuse lung diseases: Assessment with helical CT-preliminary observations of the role of maximum and minimum intensity projection images. Radiology 1996;200:341-347
46. Remy-Jardin M, Remy J, Artaud D, Deschildre F, Duhamel A. Diffuse infiltrative lung disease: Clinical value of sliding-thin-slab maximum intensity projection CT sans in the detection of mild micronodular patterns. Radiology 1996; 200:333-339
47. Lentz D, Bergin CJ, Berry GJ, Stoehr C, Theodore J. Diagnosis of bronchiolitis obliterans in heart-lung transplant patients: importance of bronchial dilatation on CT. Am J Roentgenol 1992;159:463-467
48. Costabel U. BAL characteristics of the bronchiolar diseases. In: Epler GR, ed. Diseases of the Bronchioles. New York: Raven Press; 1994:59-76
49. Nagai S, Aung M, Tanoka S, et al. Bronchoalveolar lavage cell findings in patients with BOOP and related diseases. Chest 1992;102(Suppl.):329S-375S
50. DiGiovine B, Lynch JP III, Martinez F, Flint A, et al. Neutrophilic alveolitis in oblilerative bronchiolitis after lung transplantation: role of interleukin-8. J Immunol 1996; 157:4194-4202
51. Purcell IF, Bourke SJ, Marshall SM. Cyclophosphamide in severe steroid-resistant bronchiolitis obliterans organizing pneumonia. Respir Med 1997;91:175-177
52. Lynch JP, III, McCune WJ. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders: State of The Art. Am J Respir Crit Care Med 1997;155:395-420
53. Hakler M, Paakko P, Huhti E. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990;9:452-460
54. Joseph J, Sahn SA. Connective tissue diseases and the pleura. Chest 1993;104:262-270
55. Lynch JP, III, Orens JB, Kazerooni. Collagen vascular diseases. In: Sperber M, ed. Diffuse Lung Diseases. London: Springer-Verlag; 1999;325-355
56. Anaya JM, Diethelm L, Ortiz LA, Gutierrez M, Citera G, Welsh RA, Espinoza LR. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995;24: 242-254
57. Roschmann RA, Rothenberg RJ. Pulmonary fibrosis in rheumatoid arthritis: A review of clinical features and therapy. Arthritis Rheum 1987;16:174-185
58. Todd NW, Wise RA. Respiratory complications in the collagen vascular diseases. Clin Pulm Med 1996;3:101-112
59. Wiedemann HP, Matthay RA. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989;10: 677-721
60. Wise RA. Pulmonary complications in collagen vascular disease. In: Lynch JP III, DeRemee RA, eds. Immunologically Mediated Pulmonary Diseases. JB Lippincott: Philadelphia, PA 1991:40-88
61. Penny WJ, Knight RK, Rees AM, et al. Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis 1982;41; 469-472
62. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;131:770-777
63. Ippolito JA, Palmer L, Spector S, et al. Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Semin Arthritis Rheum 1993;23:70-78
64. van Thiel RJ, vanderBurg S, Groote AD, et al. Bronchiolitis obliterates organizing pneumonia and rheumatoid arthritis. Eur Respir J 1991;4:905-911
65. Begin R, Masses S, Cantin A. Airway disease in a subset of non-smoking rheumatoid patients: Characterization of the disease and evidence of an autoimmune pathogenesis. Am J Med 1982;72:743-750
66. McMahon MJ, Swinson DR, Shettar S, et al. Bronchiectasis and rheumatoid arthritis: A clinical study. Ann Rheum Dis 1993;52:776-779
67. Hillarby MC, McMahon MJ, Grennan DM, et al. HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease. Br J Rheumatol 1993;32:794-797
68. Shadick NA, Fanta CH, Weinblatt ME, et al. Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore) 1994;73:161-170
69. Zitnik RJ, Cooper JA Jr. Pulmonary disease due to antirheumatic agents. Clin Chest Med 1990;11:139-154
70. Hargraves MR, Mowat AG, Bensou MK. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: Report of five cases and review of published reports. Thorax 1992;47:628-633
71. Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambte B. Lung changes in rheumatoid arthritis: CT findings. Radiology 1994;193:375-382
72. Fuji M, Adachi S, Shimizu T, et al. Interstitial lung disease in rheumatoid arthritis: Assessment with high resolution computed tomography. J Thorac Imaging 1993;8:54-62
73. Gabbay E, Tarala R, Will R, Carroll G, Adler B. Cameron D, Lake RT. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156: 528-535
74. McDonagh J, Greaves M, Wright AR, Heycock C, Owen JP, Kelly C. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994;33:118-122
75. Collins RL, Turner RA, Johnsen AM, Whitley NO, McLean RL. Obstructive pulmonary disease in rheumatoid arthritis. Arthritis Rheum 1976;19:623-628
76. Geddes DM, Webley M, Emerson PA. Airways obstruction in rheumatoid arthritis. Ann Rheum Dis 1979;38:222-225
77. Mountz JD, Turner RA, Collins RI, Gallup KR, Semble EI. Rheumatoid arthritis and small airways function: Effects of disease activity, smoking, and alpha-1-antitrypsin deficiency. Arthritis Rheum 1984;27:728-736
78. Vergnenegrer A, Pugnere N, Antonini MT, Arnaud M, Melloni B, Treves R, Baonnaud F. Airway obstruction and rheumatoid arthritis. Eur Respir J 1997;10:1072-1078
79. Banks J, Banks C, Cheong B, Umachandran V, Smith AP, Jessop JD, Pritchard MH. An epidemiological and clinical investigation of pulmonary function and respiratory function and respiratory symptoms in patients with rheumatoid arthritis. QJ Med 1992;307:795-806
80. Hyland RU, Gordon DA, Broder I, Davies GM, et al. A systemic controlled study of pulmonary abnormalities in rheumatoid arthritis. J Rheumatol 1983;10:395-405
81. Hassan WU, Keaney NP, Holland CD, Kelly CA. Bronchial hyperreactivity and airflow obstruction in rheumatoid arthritis. Ann Rheum Dis 1994;53:511-514
82. Hassan WU, Keaney NP, Holland CD, Kelly CD. High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:308-310
83. Epler GR, Snider GL, Gaensler EA, Cathcart ES, Fitzgerald MX, Carrington CB. Bronchiolitis and bronchitis in connective tissue disease: A possible relationship to the use of penicillamine. JAMA 1979;242:528-532
84. Holness L, Tenenbaum J, Cooter NBE, Grossman RF. Fatal bronchiolitis obliterans associated with chrysotherapy. Ann Rheum Dis 1983;42:593-596
85. Van de Laar MAFJ, Westermann CJJ, Wagenaar SS, Dinant HJ. Beneficial effect of intravenous cyclophosphamide and oral predisone on D-penicillamine associated bronchiolitis obliterans. Arthritis Rheum 1985;28:93-97
86. Hakler M, Paakko P, Sutinen S, Huhti E, Koivisto O, Tarkka M. Association of bronchiolitis with connective tissue disorders. Ann Rheum Dis 1986;45:656-662
87. Murphy KC, Atkins CJ, Offer RC, Hogg JC, Stein HB. Obliterative bronchiolitis in two rheumatoid arthritis patients treated with penicillamine. Arthritis Rheum 1981;24: 557-560
88. Lahdensuo A, Mattila J, Vilppula A. Bronchiolitis in rheumatoid arthritis. Chest 1984;85:705-708
89. Cooney TP. Interrelationship of chronic eosinophilic pneumonia, bronchiolitis obliterans, and rheumatoid disease: a hypothesis. J Clin Pathol 1981;34:129-137
90. Herzog CA, Miller RR, Hoidal RR. Bronchiolitis and rheumatoid arthritis. Am Rev Respir Dis 1981;124:636-639
91. Yam LY, Wong R. Bronchiolitis obliterans and rheumatoid arthritis. Report of a case in a Chinese patient on d-penicillamine and review of the literature. Ann Acad Med, Singapore 1993;22:365-368
92. Swhwarz MI, Lynch DA, Tuder R. Bronchiolitis obliterans: the lone manifestation of rheumatoid arthritis? Eur Respir J 1994;7:817-820
93. Jansen HM, Elema JD, Hylkerma BS, et al. Progressive obliterative bronchiolitis in a patient with rheumatoid arthritis. Eur J Respir Dis 1982;63:43-52
94. Sweatman MC, Markwick JR, Charles PJ, et al. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis. Dis Markers 1986;4:19-26
95. Scott TE, Wise RA, Hochberg MC, Wigley FM. HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis. Am J Med 1987;82:765-771
96. Rees JH, Woodhead MA, Sheppard MN, duBois RM. Rheumatoid arthritis and cryptogenic organizing pneumonia. Respir Med 1991;85:243-246
97. Swinson DR, Symmons D, Suresh U, Jones M, Booth J. Decreased survival in patients with co-existing rheumatoid arthritis and bronchiectasis. Br J Rheumatol 1997;36: 689-691
98. Andonopoulos AP, Constantopoulos SH, Galanopoulou V, et al. Pulmonary function on nonsmoking patients with systemic lupus erythematosus. Chest 1988;94:312-315
99. Toews GB, Lynch JP III. Pathogenesis and clinical features of pulmonary infections in patients with rheumatic disease. In: Cannon G., Zimmerman G., ed(s). The Lung in Rheumatic Diseases. New York: Marcel Dekker, Inc. 1990: Vol. 45, pp. 179-226
100. Schwarz MI. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging 1992;7:46-54
101. Tazelaar H, Viggiano R, Pickersgill J, Colby T. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-733
102. Adams-Grandhi LB, Boyd AS, King LE. Diagnosis and management of dermatomyositis. Compr Ther 1996;22:156-164
103. Ikezoe J, Johkoh T, Kohno N, Takeuchi N, Ichikado K, Nakamura H. High resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging 1996;11:250-259
104. Lakhanapal S, Lie JT, Conn DL, Martin WJ, II. Pulmonary disease in polymyositis/dermatomyositis: A clinicopathological analysis of 65 cases. Ann Rheum Dis 1987;47:23-29
105. Marguerie C, Bunn CC, Beynon H, Bernstein RM, Hughes JM. Polymyositis, pulmonary fibrosis, and autoantibodies to aminoacyl-tRNA synthetase enzymes. QJ Med 1990; 77:1019-1038
106. Targoff IN, Arnett FA, Berman L, O'Brien C, Reichlin M. Anti-KJ: A new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest 1989;84:162-172
107. Fata F, Rathore R, Schiff C, Herzlich BC. Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis. South Med J 1997;90:227-230
108. Schwarz MI, Matthay RA, Sahn SA, et al. Interstitial lung disease in polymyositis and dermatomyositis: Analysis of six cases and review of the literature. Medicine (Baltimore) 1976;55:89-104
109. Iwata M, Sato A, Kitazawa H, et al. Clinicopathological study of various lung diseases with bronchiolitis obliterans with organizing pneumonia (BOOP) pattern on open lung biopsy. Jpn J Thorac Dis 1991;29:1582-1590
110. Salmeron G, Greenberg SD, Lidsky MD. Polymyositis and diffuse interstitial lung disease: A review of the pulmonary histopathologic findings. Arch Intern Med 1981;141: 1005-1110
111. Imasaki T, Yoshii A, Tanaka S, Ogura T, Ishikawa A, Takahashi T. Polymyositis and Sjogren's syndrome associated with bronchiolitis obliterans organizing pneumonia. Internal Med 1996;35:231-235
112. Hsue Y, Paulus H, Coulson W. Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with long term survival. J Rheumatol 1993;20:877-879
113. Shinohara T, Hidaka T, Matsuke Y, Ishizuka T, Takamizawa M, Kawakaini M, Kikuma H, Suzuki K, Nakamura H. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Internal Med 1994;36:448-449
114. Bolster MB, Silver RM. Therapy of scleroderma lung disease. Clin Pulm Med 1996;3:314-322
115. Silver RM, Miller KS. Lung involvement in systemic sclerosis. Rheumatic Dis Clin North Am 1990;16:199-216
116. Wells AU, Cullinan P, Hansell DH, Rubens MB, Black CM, Newman-Taylor AJ, Du Bois RM. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994;149:1583-1590
117. Wells AU, Hansell DM, Rubens MB, Cailes JB, Black CM, du Bois RM. Functional impairment in long cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis. A comparison. Am J Respir Crit Care Med 1997;155:1657-1664
118. Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron PY. Pulmonary involvement in progressive systemic sclerosis: Sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 1993;188:499-506
119. Peters-Golden M, Wise RA, Hochberg MC, Stevens MB, Wigley FM. Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med 1984; 77:1027-1034
120. Peters-Golden M, Wise RA, Schneider P, Hochberg M, Stevens MB, Wigley F. Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) 1984;63:221-231
121. Bjerke RD, Tashkin DP, Clements PJ, Chopra SK, Gong H Jr, Bein M. Small airways in progressive systemic sclerosis (PSS). Am J Med 1979;66:201-209
122. Yousem SA. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 1990;21:467-474
123. Harrison MK, Myers R, Corrin B, Soosay G, Dewar A, Black CM, du Bois RM, Turner-Warwick M. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144:706-713
124. Davison AG, Epstein O. Relapsing organizing pneumonitis in a male patient with primary biliary cirrhosis, CREST syndrome and chronic pancreatitis. Thorax 1983;38: 316-317
125. Bridges AJ, Hsu KC, Dias-Arias AA, Chechani V. Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol 1992;19:1136-1140
126. Boehler A, Vogt P, Speich HR, Weder W, Russi EW. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine. Eur Respir J 1996;9:1317-1319
127. Steen VD, Lanz JK Jr, Conte C, Owens GR, Medsger TA Jr. Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum 1994;37: 1290-1296
128. Akesson A, Scheja A, Lundin A, Wollheim FA. Improved pulmonary function in systemic sclerosis alter treatment with cyclophosphamide. Arthritis Rheum 1994;37:729-735
129. Deheinzelin D, Capelozzi VL, Kairalla RA, Filho JVB, Saldiva PHN, de Carvalho CRR. Interstitial lung disease in primary Sjogren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996;154:794-799
130. Orens J, Martinez F, Lynch JP III. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Clin North Am 1994;20:159-193
131. Andronopoulos AP, Costantopoulos SH, Galanopoulou V, Drosos AA, et al. Pulmonary function in non-smoking patients with systemic lupus erythematosus. Chest 1988; 92:312-315
132. Groen H, ter Borg EJ, Postma DS, Wouda AA, VanDerMark TW, Kallenberg CGM. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic and nailfold capillary patterns. Am J Med 1992;93: 619-627
133. Nadorra RL, Landing BH. Pulmonary lesions in childhood onset systemic lupus erythematosus; analysis of 26 cases, and summary of the literature. Pediatr Pathol 1987;7:1-18
134. Kinney WW, Angelillo VA. Bronchiolitis in systemic lupus erythematosus. Chest 1982;82:646-649
135. Gammon RB, Bridges TA, Al-Nezir H, Alexander CB, Kennedy JI. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythamtosus. Chest 1992;102:1171-1174
136. Otsuka F, Amano T, Hashimoto N, Takahashi M, Hayakawa N, et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody. Internal Med 1996;35:341-344
137. Mana F, Mets T, Vincken W, Sennesael J, Vanwaeyenbergh J, Gooseens A. The association of bronchiolitis obliterans organizing pneumonia, systemic lupus erythematosus, and Hunner's cystitis. Chest 1993;104:642-644
138. Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: Review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1974;54:397-409
139. Godeau B, Cormier C, Menkes CJ. Bronchiolitis obliterans in SLE: Beneficial effects of intravenous cyclophosphamide. Ann Rheum Dis 1991;50:956-958
140. Citera G, Lazaro MA, Maldonado Cocco JA. Mixed connective tissue disease: Fact or fiction? Lupus 1995;4:255-257
141. Sullivan WD, Hurst DJ, Harmon CE, Esther JH, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984;63:92-104
142. Bennett RM. Mixed connective tissue disease and other overlap syndromes. In: Kelley W, Harris E Jr, Ruddy S, Sledge G, eds. Textbook of Rheumatology. Philadelphia: WB Saunders, CO.; 1997;1065-1078
143. Sharp GE, Irving W, Tan E, Gould G, Holman H. Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52: 148-159
144. Lazaro MA, Maldonado Cocco JA, Catoggio LJ, Babini SM, Messina OD, Morteo OG. Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine 1989;68:58-65
145. Prakash UBS, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc 1985;60:813-821.
146. Derderian SS, Tellis CJ, Abbrecht PH, Welton RC, Rajagopal KR. Pulmonary involvement in mixed connective tissue disease. Chest 1985;88:45-48
147. Suzki M, Shimizu K, Sakamoto K, et al. Interstitial pneumonia associated with mixed connective tissue disease-marked improvement with azathioprine. Jpn J Thorac Dis 1996;34:101-105
148. Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fanci FS, Frank MM, Lawley TJ, Hamburger MI. Sjogren's Syndrome (Sicca Syndrome). Current Issues Ann Intern Med 1980;92:212-226
149. Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjogren's syndrome. Mayo Clin Proc 1989;64:920-931
150. Strimlan CV, Rosenow EC, III, Divertie MB, Harrison EG, Jr. Pulmonary manifestations of Sjogren's syndrome. Chest 1976;70:354-361
151. Gardiner P, Ward C, Allison A, Ashcroft T, Simpson W, Walters H, Kelly C. Pleuropulmonary abnormalities in primary Sjogren's syndrome. J Rheum 1993;20:831-837
152. Hatron PY, Wallaert B, Gosset D, Tonnel AB, Gosselin B, Voisin C, Devulder B. Subclinical lung inflammation in primary Sjogren's syndrome: Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum 1987;30:1 226-1231
153. Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM. Alveolitis correlates with clinical pulmonary involvement in primary Sjogren's syndrome. Chest 1991;99:1394-1397
154. Papthanasiou MP, Constantopoulos SH, Tsampoulas C, Drosos AA, Moutsopoulos HM. Reappraisal of respiratory abnormalities in primary and secondary Sjogren's syndrome: A controlled study. Chest 1986;90:370-374
155. Fairfax AJ, Haslam PL, Pavia P, Sheahan NF, Batement RM, Agnew JE, Clarke SW, Turner-Warwick M. Pulmonary disorders associated with Sjogren's syndrome. Q J Med 1981;199:279-295
156. Constantopoulos SH, Papadrimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjogren's syndrome: A clinical, functional and histologic study. Chest 1985;88:226-229
157. Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjogren's syndrome: A cross sectional and longitudinal study. Thorax 1991;46:180-183
158. Lahdensuo A, Korpela M. Pulmonary findings in patients with primary Sjogren's syndrome. Chest 1995;108:316-319
159. Newball HH, Brahim SA. Chronic obstructive airway disease in patients with Sjogren's syndrome. Am Rev Respir Dis 1977;115:295-304
160. Koss MK. Pulmonary lymphoid disorders. Semin Diagn Pathol 1995;12:158-171
161. Radota J, Kusano S, Kawakami K, et al. Usual interstitial pneumonia associated with primary Sjogren's syndrome. Chest 1995;108:1756-1758
162. Matteson EL, Ike RW. Bronchiolitis obliterans organizing pneumonia associated with primary Sjogren's syndrome. J Rheum 1990;17:676-679
163. Usui Y, Kimula Y, Miura H, et al. A case of bronchiolitis obliterans organizing pneumonia associated with primary Sjogren's syndrome who died of superimposed diffuse alveolar damage. Respiration 1992;59:122-124
164. Fortoul TI, Cano-Valle F, Oliva E, Barrios R. Follicular bronchiolitis in association with connective tissue disorders. Lung 1985;163:305-314
165. Tsuzaka K, Akama H, Yamada H, Akizuki M, Tojo T, Homma M. Pulmonary pseudolymphoma presented with a mass lesion in a patient with primary Sjogren's syndrome: Beneficial effect of intermittent intravenous cyclophosphamide Scand J Rheum 1993;22:90-93
166. Butland RJA, Cole P, Citron K, Turner-Warwick M. Chronic bronchial suppuration and inflammatory bowel disease. QJ Med 1981;197:63-75
167. Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993; 72:151-183
168. Rickli H, Frertz C, Hoffman M, Walser A, Knoblauch A. Severe inflammatory upper airway stenosis in uclerative colitis. Eur Respir J 1994;7:1899-1902
169. Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am 1990;74: 39-50
170. Tzanakis N, Samiou M, Bouros D, Mouzas J, Kouroumalis E, Siafakas NM. Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med 1998;157:382-386
171. Swinburn CR, Jackson CJ, Cobden I, Ashcroft T, Morritt GN. Bronchiolitis obliterans organizing pneumonia in a patient with ulcerative colitis. Thorax 1988;43:735-736
172. Williams T, Eidus L, Thomas P. Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy. Chest 1982; 81:766-768
173. Mahajan L, Kay M, Wyllie R, Steffen R, Goldfarb J. Ulcerative colitis presenting with bronchiolitis obliterans organizing pneumonia in a pediatric patient. Am J Gastroenterol 1997;92:2123-2124
174. Chien SM, Jambrosic J, Mintz S. Pulmonary manifestations in Sweet's syndrome: First report of a case of bronchiolitis obliterans organizing pneumonia. Am J Med 1991;91: 553-554
175. Pegg SJ, Lang BA, Mikhail EL, Hughes DM. Fatal bronchiolitis obliterans in a patient with juvenile rheumatoid arthritis receiving crysotherapy. J Rheumatol 1994;21: 549-551
176. Zackrison L, Katz P. Bronchiolitis obliterans organizing pneumonia associated with essential mixed cryoglobulinemia. Arthritis Rheum 1993;36:1627-1630
177. Turner F, Enzenauer RJ. Bronchiolitis obliterans and organizing pneumonia associated with ankylosing spondylitis. Arthritis Rheum 1994:37:1557-1559
178. Robinson BW, Sterrett G. Bronchiolitis obliterans associated with polyarteritis nodosa. Chest 1992;102:309-311
179. Hernandez TL, Gomez-Roman J, Rodrigo E, Olmos JM, et al. Bronchiolitis obliterans and IgA nephropathy. A new cause of pulmonary-renal syndrome. Am J Respir Crit Care Med 1997;156:665-668
180. Endo Y, Hara M Glomerular IgA deposition in pulmonary diseases. Kidney Int 1986;29:557-562
181. D'Amico G, Imbasciati E, Di Belgioioso GB, Bertoli S, et al. Idiopathic IgA mesangial nephropathy: Clinical and histological study of 374 patients. Medicine (Baltimore) 1985;64:49-60